Literature DB >> 23516905

[Analysis of the rs12720208 single-nucleotide polymorphism of the FGF20 gene in Russian patients with sporadic Parkinson's disease].

V V Ustinova, M I Shadrina, E Iu Fedotova, S N Illarioshkin, S A Limborskaia, P A Slominskiĭ.   

Abstract

Parkinson's disease (PD) is a multifactorial neurodegenerative disease whose pathogenesis involves a number of genes and environmental factors. The FGF20 gene encoding the fibroblast growth factor and paying an important role neuron proliferation and survival is one of candidate genes of PD. There is evidence that this gene is also involved in the control of alpha-synuclein (SNCA) gene expression. The rs12720208 single-nucleotide polymorphism (SNP) in the FGF20 gene has been found to be associated with PD; it has been located to the 3'-UTR binding site for microRNA-433, which is involved in the control of FGF20 expression. Therefore, the frequency distribution of rs12720208 genotypes in the FGF20 gene has been analyzed in a sample of patients with sporadic PD and a control sample of the Russian population. The results have not shown any effect of rs12720208 in the FGF20 gene on the risk of PD in patients residing in Russia (OR = 0.95, the 95% confidence interval (CI) is 0.55-1.63, p = 0.9).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23516905

Source DB:  PubMed          Journal:  Genetika        ISSN: 0016-6758


  3 in total

1.  Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.

Authors:  Wei Quan; Jia Li; Li Liu; Qinghui Zhang; Yidan Qin; Xiaochen Pei; Jiajun Chen
Journal:  Neurol Sci       Date:  2021-11-29       Impact factor: 3.830

2.  Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.

Authors:  Xianjing Zhao; Yanfeng Wu; Can Zhao; Meijiang Feng
Journal:  Neurol Sci       Date:  2016-03-29       Impact factor: 3.307

3.  Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis.

Authors:  Ruixia Zhu; Ying Zhu; Xu Liu; Zhiyi He
Journal:  Neurol Sci       Date:  2014-06-19       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.